Charles River Laboratories International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRL research report →
About the company
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region.
- CEO
- James C. Foster
- IPO
- 2000
- Employees
- 18,700
- HQ
- Wilmington, MA, US
Price Chart
- Market Cap
- $11.11B
- P/E
- -61.52
- P/S
- 2.76
- P/B
- 3.84
- EV/EBITDA
- 48.10
- Div Yield
- 0.00%
- Gross Margin
- 31.86%
- Op Margin
- 11.77%
- Net Margin
- -4.59%
- ROE
- -5.74%
- ROIC
- 7.14%
- Revenue
- $4.02B · -0.85%
- Net Income
- $-144,338,000 · -1501.75%
- EPS
- $-2.91 · -1555.00%
- Op Income
- $507.84M
- FCF YoY
- 3.37%
- 52W High
- $236.62
- 52W Low
- $144.26
- 50D MA
- $180.40
- 200D MA
- $180.44
- Beta
- 1.45
- Avg Volume
- 884.61K
Get TickerSpark's AI analysis on CRL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | FOSTER JAMES C | sell | 75,000 |
| Jun 5, 26 | FOSTER JAMES C | other | 153,361 |
| Jun 5, 26 | FOSTER JAMES C | other | 153,361 |
| Jun 5, 26 | FOSTER JAMES C | other | 20,000 |
| Jun 5, 26 | FOSTER JAMES C | other | 20,000 |
| Jun 5, 26 | FOSTER JAMES C | other | 10,000 |
| Jun 5, 26 | FOSTER JAMES C | other | 10,000 |
| Jun 5, 26 | Girshick Birgit | other | 3,386 |
| Jun 5, 26 | Girshick Birgit | other | 3,386 |
| Jun 5, 26 | Parisotto Shannon M | other | 1,529 |
Our CRL coverage
Recent articles, reports, and earnings notes.
No research on CRL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRL report →Similar companies
Peers in the same neighborhood.